PHK
FULC icon

Point72 Hong Kong’s Fulcrum Therapeutics FULC Stock Holding History

Point72 Hong Kong’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,495
Closed -$22K – 2087
2022
Q2 		$22K Buy
+4,495
New +$43.9K ﹤0.01% 1536
2022
Q1 		– Sell
-982
Closed -$17K – 2020
2021
Q4 		$17K Buy
+982
New +$19.5K ﹤0.01% 1568
2021
Q2 		– Sell
-90
Closed -$1K – 2063
2021
Q1 		$1K Buy
+90
New +$1.11K ﹤0.01% 1721

Other funds holding FULC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Point72 Hong Kong's FULC Position: Q3 2022 in Review

Point72 Hong Kong sold out of Fulcrum Therapeutics (FULC) in Q3 2022, closing a stake of 4,495 shares — an estimated $22K sold.

Point72 Hong Kong first reported a position in FULC in Q1 2021 and held it in 3 quarters. The position peaked at $22K in Q2 2022. 105 funds tracked by Wall St. Rank hold FULC as of Q3 2022.

  • Point72 Hong Kong reported no remaining Fulcrum Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 4,495 Fulcrum Therapeutics shares in Q3 2022, an estimated $22K.
  • Point72 Hong Kong first reported a position in Fulcrum Therapeutics in Q1 2021 and held it in 3 quarters.
  • Point72 Hong Kong's Fulcrum Therapeutics position peaked at $22K in Q2 2022.
  • 105 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.